Authors
Loading...
Review highlights immunogenicity and personalized approaches of mRNA vaccines in melanoma, suggesting efficacy with immune checkpoint inhibitors.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: